Status: Not yet recruiting
Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy
Based on previous basic experiments revealing that patients with type 2 diabetic nephropathy exhibit higher blood lead levels than the general population, this study aims to systematically evaluate the impacts of short-term and long-term blood lead exposure on renal function progression in such patients, so as to provide novel epidemiological evidence for clinical intervention.
Participants needed: 42
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: The Fourth Affiliated Hospital of Zhejiang University School of MedicineUpdated: Jul 16, 2026
Eligibility criteria
1. Diagnosed with type 2 diabetic nephropathy; 2. Baseline blood lead level ≥5 µ...
1. Combined hypertension; 2. Combined hyperlipidemia; 3. History of autoimmune d...